SafeRx Pharma

SafeRx Pharma is a pharmaceutical startup with the mission of making prescription medications safer. The company is focused on addressing a critical dimension of the U.S. opioid crisis - the combination of opioids with alcohol. SafeRx Pharmaceuticals is currently in the development stage and is seeking investments to support the clinical development programs of its inaugural Alcohol-Resistant Opioid (ARO) products. These products are intended for the treatment of opioid use disorder (OUD) in patients with concurrent alcohol use disorder (AUD), a patient segment for which effective dual-treatment options are currently lacking. Founded in 2021, SafeRx Pharma operates in the Health Care and Pharmaceutical industries and is headquartered in the United States. As a venture capital analyst, the disruptive potential of SafeRx Pharma's innovative approach to addressing the opioid crisis presents an intriguing investment opportunity in a critical and evolving sector.